Navigation Links
How Best to Treat Preschoolers With ADHD? The Harvard Mental Health Letter Discusses the Options
Date:9/4/2007

BOSTON, Sept. 4 /PRNewswire-USNewswire/ -- Attention-deficit/hyperactivity disorder (ADHD) is no longer diagnosed just in schoolchildren. ADHD has already become the most common mental health diagnosis for children ages 3 to 5. Researchers have now begun to explore the use of drugs and other treatments for preschoolers, reports the September 2007 issue of the Harvard Mental Health Letter.

At the preschool age, it can be hard to tell whether certain behaviors represent a real problem or just "kids being kids." Clinicians compare a child with others the same age to determine whether the symptoms are inconsistent with the developmental level. Preschoolers with ADHD are not just rambunctious. They seem unable to wait their turn or think before acting. Despite warnings, they may play with matches or rush into traffic. They are noisy and constantly interrupt others, and they can sow chaos at home or in day care.

Stimulant drugs are increasingly prescribed for younger children, although the FDA has not approved them for children under age 6. The first large, controlled trial of methylphenidate (Ritalin and others) in children ages 3 to 5 found the drug was not quite as effective as it is in school-age children.

The most popular alternative to drug treatment is parent training, which is based on the belief that parental negligence, intrusiveness, or harsh discipline might trigger hyperactive behavior in a child with a predisposition to poor impulse control. Parents are shown how to set appropriate limits and use moderate rewards and punishments. The bottom line, according to the Harvard Mental Health Letter: Be slow to make the diagnosis, and consider parent training and specialized day care before resorting to stimulant drugs.

Also in this issue:

-- Endophenotypes: A new way to look at psychiatric disorders

-- Ignoring hallucinatory voices

-- When both partners are violent

-- Muscle relaxation

-- Borderline personality disorder

-- Children, depression, and the FDA

The Harvard Mental Health Letter is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $59 per year. Subscribe at http://www.health.harvard.edu/mental or by calling 1-877-649-9457 (toll free).

Media: Contact Christine Junge at Christine_Junge@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.


'/>"/>
SOURCE Harvard Mental Health Letter
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Thyroid hormone treatment hastens recovery after cardiac surgery
4. Feeding channel created by malaria parasite - a new target for malaria treatments
5. New drug to treat Heart Attack and damaged tissue
6. Now umbilical cord helps in stroke treatment.
7. Now AIDS treatment comes dirt-cheap
8. Breast cancer treatment to be determined by gene test
9. Hemopurifier may revolutionise AIDS treatment
10. New drug helps boost cancer treatment
11. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... February 19, 2017 , ... Braun Industries will be ... & Exposition, the event will take place February 23-25, 2017 at the Calvin L. ... in Booth #909 with three new ambulances on display. , “JEMS ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, not ... the industry, according to the recent NEJM Catalyst Insights Report on the New ... NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, and ...
(Date:2/18/2017)... ... February 18, 2017 , ... A new directory from ... points to easily connect elderly veterans of America's armed forces to a range ... also conveys material on this year's increase in the Veterans Pension with Aid ...
(Date:2/17/2017)... ... 2017 , ... For the first time, International Scholarship and ... floor for the 2017 HIMSS Conference & Exhibition at the Orange ... than 40,000 healthcare industry professionals are expected at the conference, where they will ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... -- Research and Markets has announced the addition of the ... ... comprehensive analytics for the US, Canada , ... , Latin America , and Rest of World. Annual ... a six-year historic analysis is provided for these markets. Market data and ...
(Date:2/17/2017)... NEW HAVEN, Conn. , Feb. 17, 2017 /PRNewswire/ ... new class of drugs based on protein degradation, today ... oral androgen receptor (AR) PROTAC during a poster session ... Cancers Symposium (ASCO GU) in Orlando, FL. ... today continue to validate our platform and the potential ...
(Date:2/17/2017)... 2017   Risperdal lawsuits involving gynecomastia (male breast ... use of the atypical antipsychotic medication continue to move ... of Common Pleas, where the state,s Risperdal docket has ... a notice posted on the Court,s website , ... March 9, 2017 at 11:00 a.m. (In Re: Risperdal ...
Breaking Medicine Technology: